Slovenia Krka Pharmaceuticals is Sri Lanka's largest pharmaceutical manufacturer. According to Sri Lanka's "Workday" 2005 ranking of companies, Korka Pharmaceutical Factory ranked first with net profit of 97.43 million euros.
In 2005, the Korka Pharmaceutical Factory imported approximately 12 million euros of pharmaceutical raw materials (medicinal intermediates) from China. Its partners are mainly located in Zhejiang, Chengdu, Beijing, and Guangdong. At present, Korka Pharmaceuticals vigorously strengthens cooperation with chemical and pharmaceutical research institutes in Shanghai and Chengdu to jointly develop chemical synthetic drugs and gradually expand imports of pharmaceutical raw materials from China, and plans to increase the scale and form of cooperation with China in the next few years. , From simple imports, to expand cooperation and research and development, and plans to invest in setting up factories. In order to achieve this goal, in April 2006, Kolka Pharmaceuticals established an office in Shanghai.
Founded on April 23, 1954, the Korka Pharmaceutical Factory was formerly a small chemical laboratory. After 52 years of hard work, Korka Pharmaceuticals has developed into a listed company that is engaged in the production of pharmaceuticals, cosmetics, veterinary drugs and health products. Among them, state-owned shares accounted for 25%.
At present, Korca Pharmaceuticals ranks 15th among the world's pharmaceutical companies and 7th among its European counterparts. In 2005, the total sales amounted to 700 million euros, and a total of 6.3 billion kinds of pharmaceutical products were produced and sold in 70 countries. There are 5596 employees and overseas employees account for 1/3 of the total number of employees.
I. Production and operation
Korka's pharmaceutical products are mainly pharmaceutical products, of which 79% are prescription drugs, 11% are non-prescription drugs, 4% are veterinary drugs, 2% are cosmetics, and 4% are health products.
Of the pharmaceutical products, 48.1% were drugs for treating cardiovascular diseases; 15.7% were drugs for digestive diseases; 14.7% were antibiotics; 10% were drugs for treating nervous system diseases; and the rest were drugs for other diseases.
The medicine market of Korka Pharmaceutical Factory is mainly in Europe, and exports to Western Europe, Central Europe, Eastern Europe, and Southern Europe account for 25%, 25%, 15%, and 17% of the total amount of the local market. Sales in Slovenia account for 18% of the total market, and other markets outside Europe account for 10%.
In 2005, the total R&D expenditure of Korca Pharmaceutical Factory was 16 million euros, which accounted for 8% of its total revenue. In 2005, the proportion of new drug products in its pharmaceutical products was 46%. At present, Korca has 400 R&D personnel and can develop more than 100 new drug varieties each year.
Up to now, Korka Pharmaceuticals has been in Albania, Azerbaijan, Belarus, Bosnia and Herzegovina, Serbia, Bulgaria, Czech Republic, China, Estonia, Georgia, Hungary, India, Kazakhstan, Latvia, Lithuania, Moldova, Slovakia, Ukraine, Romania. Uzbekistan set up a representative office and set up factories in Poland, Russia and Croatia.
Second, Korca's development plan
In order to maintain the sustainable development of the company's business, Korka Pharmaceuticals has formulated a development plan for 2006-2010:
(A) priority to the development of the European and Central Asian markets; enhance creativity, development of new drugs and biopharmaceuticals, expand prescription and non-prescription drugs range of products; market development priorities, key buyers, key products;
(B) to promote public awareness and independence Colca brand; international enterprise transformation, to strengthen internal management and vertical integration with the group, play a competitive advantage;
(C) a positive commitment to economic, social and environmental responsibility, increase investment in environmental protection, the improvement of living, quality of work of employees.
In 2005, the Korka Pharmaceutical Factory imported approximately 12 million euros of pharmaceutical raw materials (medicinal intermediates) from China. Its partners are mainly located in Zhejiang, Chengdu, Beijing, and Guangdong. At present, Korka Pharmaceuticals vigorously strengthens cooperation with chemical and pharmaceutical research institutes in Shanghai and Chengdu to jointly develop chemical synthetic drugs and gradually expand imports of pharmaceutical raw materials from China, and plans to increase the scale and form of cooperation with China in the next few years. , From simple imports, to expand cooperation and research and development, and plans to invest in setting up factories. In order to achieve this goal, in April 2006, Kolka Pharmaceuticals established an office in Shanghai.
Founded on April 23, 1954, the Korka Pharmaceutical Factory was formerly a small chemical laboratory. After 52 years of hard work, Korka Pharmaceuticals has developed into a listed company that is engaged in the production of pharmaceuticals, cosmetics, veterinary drugs and health products. Among them, state-owned shares accounted for 25%.
At present, Korca Pharmaceuticals ranks 15th among the world's pharmaceutical companies and 7th among its European counterparts. In 2005, the total sales amounted to 700 million euros, and a total of 6.3 billion kinds of pharmaceutical products were produced and sold in 70 countries. There are 5596 employees and overseas employees account for 1/3 of the total number of employees.
I. Production and operation
Korka's pharmaceutical products are mainly pharmaceutical products, of which 79% are prescription drugs, 11% are non-prescription drugs, 4% are veterinary drugs, 2% are cosmetics, and 4% are health products.
Of the pharmaceutical products, 48.1% were drugs for treating cardiovascular diseases; 15.7% were drugs for digestive diseases; 14.7% were antibiotics; 10% were drugs for treating nervous system diseases; and the rest were drugs for other diseases.
The medicine market of Korka Pharmaceutical Factory is mainly in Europe, and exports to Western Europe, Central Europe, Eastern Europe, and Southern Europe account for 25%, 25%, 15%, and 17% of the total amount of the local market. Sales in Slovenia account for 18% of the total market, and other markets outside Europe account for 10%.
In 2005, the total R&D expenditure of Korca Pharmaceutical Factory was 16 million euros, which accounted for 8% of its total revenue. In 2005, the proportion of new drug products in its pharmaceutical products was 46%. At present, Korca has 400 R&D personnel and can develop more than 100 new drug varieties each year.
Up to now, Korka Pharmaceuticals has been in Albania, Azerbaijan, Belarus, Bosnia and Herzegovina, Serbia, Bulgaria, Czech Republic, China, Estonia, Georgia, Hungary, India, Kazakhstan, Latvia, Lithuania, Moldova, Slovakia, Ukraine, Romania. Uzbekistan set up a representative office and set up factories in Poland, Russia and Croatia.
Second, Korca's development plan
In order to maintain the sustainable development of the company's business, Korka Pharmaceuticals has formulated a development plan for 2006-2010:
(A) priority to the development of the European and Central Asian markets; enhance creativity, development of new drugs and biopharmaceuticals, expand prescription and non-prescription drugs range of products; market development priorities, key buyers, key products;
(B) to promote public awareness and independence Colca brand; international enterprise transformation, to strengthen internal management and vertical integration with the group, play a competitive advantage;
(C) a positive commitment to economic, social and environmental responsibility, increase investment in environmental protection, the improvement of living, quality of work of employees.
Big heavy gram Pet Preform Mold to make the prefrm weight from 50g to 750g. We do each mould according to your customer's sample and requirement.
We focus on international export product development, production, sales and after-sale service. If u want to know more information about our Pet Preform Mould, pls click the product details to view parameter, models, pictures and other information about plastic bottle preform mold.
Pet Tube Mold,Pet Bottle Mould,Plastic Pet Preform Mould,Plastic Bottle Preform Mold
WENZHOU WINIBER MACHINERY EQUIPMENT CO., LTD. , https://www.winiber-machinery.com